What are the recommended timing, device options, contraindications, insertion procedure, and follow‑up for a postpartum intrauterine contraceptive device (PPIUCD)?

Postpartum Intrauterine Contraceptive Device (PPIUCD)

Immediate postpartum IUD insertion (within 10 minutes of placental delivery) should be offered to all women during prenatal care, as it significantly improves contraceptive continuation rates and reduces unintended pregnancies, despite a higher expulsion rate compared to delayed insertion. 1

Optimal Timing

Insert the IUD within 10 minutes of placental delivery for the lowest expulsion rate (10%) in immediate postpartum placement. 1 This can be done after either vaginal or cesarean delivery. While insertion between 10 minutes to 48 hours postpartum is also feasible ("early" insertion), the immediate window (≤10 minutes) offers the best balance of access and expulsion risk. 2

The critical trade-off: Although immediate insertion has higher expulsion rates than interval placement (24% vs 2% at 6 months), continuation rates are substantially higher (80% vs 50% at 6 months) because women who plan delayed insertion often never return for the appointment. 1, 3

Device Options

Both copper and levonorgestrel-releasing devices are appropriate:

• Copper T380A (ParaGard): Category 1 (no restrictions) for most women, including those with breast cancer 1
• Levonorgestrel-releasing IUS: Category 1-2 for most conditions, safe for breastfeeding 1

The choice depends primarily on contraindications rather than timing considerations, as both have similar safety profiles for immediate postpartum insertion.

Absolute Contraindications

Delay insertion if any of the following are present: 1

Immediate Postpartum-Specific Contraindications:

• Active chorioamnionitis
• Prenatal sexually transmitted infection without test of cure
• Ongoing postpartum hemorrhage
• Retained placenta requiring manual removal or surgical evacuation
• Puerperal sepsis
• Post-septic abortion

General IUD Contraindications (US MEC Category 4):

• Distorted uterine cavity
• Wilson disease (copper IUD only)
• Current breast cancer (levonorgestrel IUD only—use copper IUD instead)
• Cervical cancer
• Endometrial cancer
• Malignant gestational trophoblastic disease
• Active pelvic inflammatory disease
• Purulent cervicitis
• Pelvic tuberculosis
• Unexplained vaginal bleeding

Key clinical pearl: When one LARC method is contraindicated, another is usually acceptable. For example, women with breast cancer can use copper IUD (Category 1) even though hormonal options are Category 4. 1

Insertion Technique

For Vaginal Delivery: 1

1. Change to sterile gloves after placental delivery
2. Remove IUD from inserter and cut strings to 10-12 cm
3. Cleanse cervix with betadine or antiseptic
4. Visualize cervix with hand or retractor; grasp anterior lip with ring forceps
5. Grasp IUD wings with ring or Kelly placental forceps
6. Pass device through cervix with gentle cervical retraction under direct visualization
7. Palpate uterine fundus abdominally to confirm fundal placement before releasing forceps
8. Release forceps laterally to avoid IUD displacement
9. Consider transabdominal ultrasound to confirm high fundal placement (reduces expulsion risk)

Critical technique point: High fundal placement significantly decreases expulsion rates. 1

For Cesarean Delivery: 1

Place IUD manually at the uterine fundus (or with ring forceps/manufacturer's inserter) after initiating hysterotomy closure. Place strings into the lower uterine segment before completing closure.

String Management:

Trim strings to 10-12 cm at insertion—they should not be visible beyond the cervix initially and can be trimmed at follow-up after uterine involution. 1

Follow-Up Protocol

Schedule follow-up at 6 weeks postpartum for:

• Clinical examination to check for string visibility
• Ultrasound if strings not visible or expulsion suspected
• Assessment for complications (pain, bleeding, infection)
• String trimming if needed

Educate patients about expulsion signs:

• Feeling the hard plastic of the IUD at cervix
• Sudden cramping or pain
• Strings feeling longer than before
• Partner feeling the device during intercourse

Additional follow-up at 3 and 6 months is reasonable given the higher expulsion risk in the first 6 months. 2, 4

Safety Profile

Immediate postpartum IUD insertion does NOT increase: 1

• Infection rates
• Uterine perforation risk
• Postpartum bleeding

The primary risk is expulsion, which occurs in approximately 10% when inserted within 10 minutes of placental delivery. 1 Expulsion rates are higher in preterm deliveries (15.3% at 12 months) compared to term deliveries (6.4% at 12 months), likely due to smaller uterine size and variations in involution. 4

Special Populations

Women at high risk for medical complications particularly benefit from immediate postpartum LARC, including those with:

• Cardiac disease
• Diabetes
• Sickle cell disease
• Thrombophilia
• Solid organ transplant
• Chronic renal or liver disease
• Peripartum cardiomyopathy

1

For these high-risk women, LARC methods are Category 1 or 2 (safe to use) for most conditions, making immediate postpartum insertion especially valuable to prevent high-risk subsequent pregnancies.

Common Pitfalls to Avoid

1. Don't wait beyond 10 minutes if planning immediate insertion—expulsion rates increase with delayed timing
2. Don't skip ultrasound confirmation of fundal placement when feasible—improves outcomes
3. Don't assume patients will return for interval insertion—offer immediate placement when appropriate
4. Don't forget to counsel prenatally—decision-making during labor is suboptimal
5. Don't overlook active infection—this is the most common reason to delay insertion

Counseling Strategy

Discuss PPIUCD during prenatal care (ideally third trimester) rather than during labor. 1 Address:

• Higher expulsion risk (10-24%) vs. delayed insertion (2%)
• Higher continuation rates (80% vs 50%) due to access barriers
• Safety profile (no increased infection, perforation, or bleeding)
• Immediate contraceptive protection
• Compatibility with breastfeeding
• Removal options if desired

The low overall acceptance rate (12-36%) 4, 5 reflects inadequate counseling and provider training rather than method limitations—structured antenatal education significantly improves uptake.